Original Research

Published on 15 Feb 2024

Global research on RNA vaccines for COVID-19 from 2019 to 2023: a bibliometric analysis

in Vaccines and Molecular Therapeutics

Ziyi Chen
Zhiliang Liu
Yali Feng
Aochen Shi
Liqing Wu
Yi Sang
Chenxi Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1259788

2,519 views
2 citations

Mini Review

Published on 14 Feb 2024

The major epidemiologic, microbiologic, immunologic, and clinical aspects of Lyme disease that form the basis for a newly developed vaccine that may become available soon for human use

in Vaccines and Molecular Therapeutics

Charles S. Pavia
Gregory Saggio
Maria M. Plummer

Frontiers in Immunology

doi 10.3389/fimmu.2023.1326623

2,587 views
2 citations

Original Research

Published on 12 Feb 2024

CD4+ Th1 and Th17 responses and multifunctional CD8 T lymphocytes associated with cure or disease worsening in human visceral leishmaniasis

in Vaccines and Molecular Therapeutics

Mariana Nobre Farias de Franca
Lorranny Santana Rodrigues
Aline Silva Barreto
Geydson Silveira da Cruz
José Carlos Aragão-Santos
Angela Maria da Silva
Amélia Ribeiro de Jesus
Clarisa B. Palatnik-de-Sousa
Roque Pacheco de Almeida
Cristiane Bani Corrêa

Frontiers in Immunology

doi 10.3389/fimmu.2024.1277557

2,393 views
1 citation

Original Research

Published on 12 Feb 2024

Fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development

in Vaccines and Molecular Therapeutics

Yi Wang
Matthew C. Troutman
Carl Hofmann
Ariel Gonzalez
Liping Song
Robert Levin
Heidi Yoder Pixley
Kristine Kearns
Pete DePhillips
John W. Loughney

Frontiers in Immunology

doi 10.3389/fimmu.2024.1356600

1,741 views

Brief Research Report

Published on 09 Feb 2024

Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2

in Vaccines and Molecular Therapeutics

Roberto Alonso
Sergio Gil-Manso
Pilar Catalán
Ignacio Sánchez-Arcilla
Marco Marzola
Rafael Correa-Rocha
Patricia Muñoz
Marjorie Pion
the Gregorio Marañón Microbiology-ID COVID-19 Study Group

Frontiers in Immunology

doi 10.3389/fimmu.2024.1341313

1,451 views
1 citation

Original Research

Published on 09 Feb 2024

Identification of conserved cross-species B-cell linear epitopes in human malaria: a subtractive proteomics and immuno-informatics approach targeting merozoite stage proteins

in Vaccines and Molecular Therapeutics

Sebastian D. Musundi
Jesse Gitaka
Bernard N. Kanoi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1352618

1,688 views

Original Research

Published on 08 Feb 2024

Oriented display of HIV-1 Env trimers by a novel coupling strategy enhances B cell activation and phagocytosis

in Vaccines and Molecular Therapeutics

Riccardo Di Vincenzo
Jannis Beutel
Philipp Arnold
Yu Wang
Dominik Damm
Pierre Tannig
Anja Lux
Vladimir Temchura
Jutta Eichler
Klaus Überla

Frontiers in Immunology

doi 10.3389/fimmu.2024.1344346

1,698 views
1 citation

Perspective

Published on 08 Feb 2024

The mRNA-LNP vaccines – the good, the bad and the ugly?

in Vaccines and Molecular Therapeutics

Botond Z. Igyártó
Zhen Qin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1336906

19,457 views
6 citations

Original Research

Published on 08 Feb 2024

IL-27 alters inflammatory cytokine expression and limits protective immunity against Mycobacterium tuberculosis in a neonatal BCG vaccination model

in Vaccines and Molecular Therapeutics

Shelby D. Bradford
Kenneth J. Ryan
Ashley M. Divens
Jessica M. Povroznik
Sunilkanth Bonigala
Cory M. Robinson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1217098

1,480 views
1 citation

Review

Published on 06 Feb 2024

Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis

in Vaccines and Molecular Therapeutics

Ying Liu
Sixin Li
Lu Chen
Lin Lin
Caijuan Xu
Huiwen Qiu
Xinyu Li
Hui Cao
Kun Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1341596

2,685 views
4 citations

Original Research

Published on 06 Feb 2024

Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages

in Vaccines and Molecular Therapeutics

Patrick Neckermann
Madlen Mohr
Martina Billmeier
Alexander Karlas
Ditte R. Boilesen
Christian Thirion
Peter J. Holst
Ingo Jordan
Volker Sandig
Benedikt Asbach

Frontiers in Immunology

doi 10.3389/fimmu.2024.1338492

1,993 views
1 citation

Correction

Published on 06 Feb 2024

Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

in Vaccines and Molecular Therapeutics

Hoi Man Ng
Chon Lok Lei
Siyi Fu
Enqin Li
Sek In Leong
Chu Iong Nip
Nga Man Choi
Kai Seng Lai
Xi Jun Tang
Chon Leng Lei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1375028

583 views

Original Research

Published on 05 Feb 2024

Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva

in Vaccines and Molecular Therapeutics

Stephan Winklmeier
Heike Rübsamen
Ceren Özdemir
Paul R. Wratil
Gaia Lupoli
Marcel Stern
Celine Schneider
Katharina Eisenhut
Samantha Ho
Hoi Kiu Wong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1330864

1,665 views
2 citations

Original Research

Published on 02 Feb 2024

A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses

in Vaccines and Molecular Therapeutics

James Tristan Gordy
Yinan Hui
Courtney Schill
Tianyin Wang
Fengyixin Chen
Kaitlyn Fessler
Jacob Meza
Yangchen Li
Alannah D. Taylor
Rowan E. Bates

Frontiers in Immunology

doi 10.3389/fimmu.2024.1292059

2,066 views
2 citations

Original Research

Published on 01 Feb 2024

Age-dependent acquisition of IgG antibodies to Shigella serotypes—a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination

in Vaccines and Molecular Therapeutics

Melissa C. Kapulu
Esther Muthumbi
Edward Otieno
Omar Rossi
Pietro Ferruzzi
Francesca Necchi
Alessandra Acquaviva
Laura B. Martin
Benedict Orindi
Kennedy Mwai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1340425

1,927 views

Review

Published on 01 Feb 2024

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects

in Vaccines and Molecular Therapeutics

Bowen Lu
Jing Ming Lim
Boyue Yu
Siyuan Song
Praveen Neeli
Navid Sobhani
Pavithra K
Srinivasa Reddy Bonam
Rajendra Kurapati
Junnian Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1332939

9,551 views
18 citations

Navigation group

Articles

Global research on RNA vaccines for COVID-19 from 2019 to 2023: a bibliometric analysis

The major epidemiologic, microbiologic, immunologic, and clinical aspects of Lyme disease that form the basis for a newly developed vaccine that may become available soon for human use

CD4+ Th1 and Th17 responses and multifunctional CD8 T lymphocytes associated with cure or disease worsening in human visceral leishmaniasis

Fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development

Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2

Identification of conserved cross-species B-cell linear epitopes in human malaria: a subtractive proteomics and immuno-informatics approach targeting merozoite stage proteins

Oriented display of HIV-1 Env trimers by a novel coupling strategy enhances B cell activation and phagocytosis

The mRNA-LNP vaccines – the good, the bad and the ugly?

IL-27 alters inflammatory cytokine expression and limits protective immunity against Mycobacterium tuberculosis in a neonatal BCG vaccination model

Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis

Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages

Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva

A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses

Age-dependent acquisition of IgG antibodies to Shigella serotypes—a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects